statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

First Wave BioPharma, Inc. (NASDAQ:FWBI  Free Report)  HC Wainwright boosted their FY2023 earnings estimates for shares of First Wave BioPharma in a report released on Monday, March...

FY2023 EPS Estimates for First Wave BioPharma, Inc. Boosted by Analyst (NASDAQ:FWBI)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

First Wave BioPharma reinstated with a Neutral at H.C. Wainwright

First Wave BioPharma acquires ImmunogenX, focusing on advancing GI pipeline. James Sapirstein remains Chairman & CEO, with Jack Syage as President & COO.'
read more...

First Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Disease

Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease James Sapirstein, Chairman and Chief Executive Officer, to continue leading First Wave...

First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline

BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing...

First Wave BioPharma to Participate In 'Fireside Chat' at the 36th Annual Roth Conference

BOCA RATON, Fla., March 04, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing...

First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering

BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing in...

First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024

Shares of First Wave BioPharma, Inc. (NASDAQ:FWBI  Get Free Report) traded down 3% during mid-day trading on Thursday . The company traded as low as $4.95 and last traded at $5.14. 159,133...

First Wave BioPharma (NASDAQ:FWBI) Trading Down 3%

BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing in...

First Wave BioPharma to Present at the DealFlow MicroCap Conference

BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), ( First Wave BioPharma or the Company ), a clinical-stage biopharmaceutical company specializing in...

First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico

First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm is involved in a therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. Its programs include FW-UP, FW-UC, FW-CD, FW-COV, FW-ICI-AC, MS1819, COVID-19 GI infections, and FW-EPI. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.

Watchers	13,255
52-Wk Low	$2.33
52-Wk High	$62.40

Volume	14,867.00
52-Wk High	$62.40
52-Wk Low	$2.33

FWBI First Wave BioPharma Inc

About

Feed

News

Fundamentals